Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patient perspectives on NHL treatment

Chircop D et al. Eur J Oncol Nurs. 2018 Aug;35:117-21

Key clinical point: Patients undergoing chemotherapy for non-Hodgkin lymphoma may experience a greater sense of isolation than patients with other types of cancer do.

Major finding: Patients reported three themes while undergoing chemotherapy: living an emotional roller coaster, becoming dependent on others, and facing an uncertain future.

Study details: A qualitative study of six adults patients with non-Hodgkin lymphoma who were undergoing chemotherapy.

Disclosures: There was no outside funding for the study and the researchers reported having no financial disclosures.

Read the article here.

Citation:

Chircop D et al. Eur J Oncol Nurs. 2018 Aug;35:117-21.

This Week's Must Reads

'New standard of care’ for CLL in younger patients, Shanafelt TD et al. ASH 2018, Abstract LBA-4

Mutation pegged as CLL resistance mechanism to venetoclax, Blombery P et al. ASH 2018, Abstract LBA-7

Guidelines for primary central nervous system lymphoma, Fox et al. Br J Haematol. 2018 Nov 23 doi: 10.1111/bjh.15661

FLYER evaluates number of R-CHOP cycles in DLBCL, Poeschel V et al. ASH 2018, Abstract 781

Ibrutinib-based therapy improves survival in CLL, Woyach JA et al. ASH 2018, Abstract 6

Must Reads in Aggressive Lymphomas

Mutation pegged as CLL resistance mechanism to venetoclax, Blombery P et al. ASH 2018, Abstract LBA-7

'New standard of care’ for CLL in younger patients, Shanafelt TD et al. ASH 2018, Abstract LBA-4

Guidelines for primary central nervous system lymphoma, Fox et al. Br J Haematol. 2018 Nov 23 doi: 10.1111/bjh.15661

FLYER evaluates number of R-CHOP cycles in DLBCL, Poeschel V et al. ASH 2018, Abstract 781

Ibrutinib-based therapy improves survival in CLL, Woyach JA et al. ASH 2018, Abstract 6